AU1940800A - Combination therapy for the treatment of sepsis - Google Patents
Combination therapy for the treatment of sepsisInfo
- Publication number
- AU1940800A AU1940800A AU19408/00A AU1940800A AU1940800A AU 1940800 A AU1940800 A AU 1940800A AU 19408/00 A AU19408/00 A AU 19408/00A AU 1940800 A AU1940800 A AU 1940800A AU 1940800 A AU1940800 A AU 1940800A
- Authority
- AU
- Australia
- Prior art keywords
- sepsis
- treatment
- combination therapy
- therapy
- combination
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Abandoned
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/43—Enzymes; Proenzymes; Derivatives thereof
- A61K38/46—Hydrolases (3)
- A61K38/48—Hydrolases (3) acting on peptide bonds (3.4)
- A61K38/482—Serine endopeptidases (3.4.21)
- A61K38/4866—Protein C (3.4.21.69)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US11312498P | 1998-12-21 | 1998-12-21 | |
US60113124 | 1998-12-21 | ||
PCT/US1999/030433 WO2000037022A2 (en) | 1998-12-21 | 1999-12-20 | Combination therapy for the treatment of sepsis |
Publications (1)
Publication Number | Publication Date |
---|---|
AU1940800A true AU1940800A (en) | 2000-07-12 |
Family
ID=22347698
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
AU19408/00A Abandoned AU1940800A (en) | 1998-12-21 | 1999-12-20 | Combination therapy for the treatment of sepsis |
Country Status (5)
Country | Link |
---|---|
EP (1) | EP1214041A2 (en) |
JP (1) | JP2002542148A (en) |
AU (1) | AU1940800A (en) |
CA (1) | CA2358492A1 (en) |
WO (1) | WO2000037022A2 (en) |
Families Citing this family (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JP4459441B2 (en) * | 1998-05-01 | 2010-04-28 | 塩野義製薬株式会社 | sPLA2 inhibitor ester |
US6140327A (en) * | 1999-05-12 | 2000-10-31 | Eli Lilly And Company | Morpholino-n-ethyl ester derivative of an indole sPLA2 inhibitor |
WO2002005796A2 (en) * | 2000-07-14 | 2002-01-24 | Eli Lilly And Company | Use of a spla2 inhibitor for the treatment of sepsis |
WO2002100445A1 (en) | 2001-06-13 | 2002-12-19 | The University Of Sydney | Treatment and composition for wound healing |
US9353113B2 (en) | 2011-03-18 | 2016-05-31 | Ono Pharmaceutical Co., Ltd. | Tetrahydrocarboline derivative |
WO2016116527A1 (en) * | 2015-01-20 | 2016-07-28 | Cynora Gmbh | Organic molecules, in particular for use in optoelectronic components |
Family Cites Families (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5093117A (en) * | 1989-01-24 | 1992-03-03 | Baxter International Inc. | Compositions and method for the treatment or prophylaxis of sepsis or septic shock |
US5571786A (en) * | 1990-08-16 | 1996-11-05 | Immuno Aktiengesellschaft | Use of protein C or the activation peptide of protein C for preparing a pharmaceutical preparation |
ES2377223T3 (en) * | 1994-04-01 | 2012-03-23 | Eli Lilly And Company | [[3- (2-Amino-1,2-dioxoethyl) -2-ethyl-1- (phenylmethyl) -11H-indole-4-IL] oxy] acetic acid methyl ester as an inhibitor of sPLA2 |
DZ2769A1 (en) * | 1998-04-17 | 2003-12-01 | Lilly Co Eli | Substituted tricyclics. |
-
1999
- 1999-12-20 CA CA002358492A patent/CA2358492A1/en not_active Abandoned
- 1999-12-20 WO PCT/US1999/030433 patent/WO2000037022A2/en not_active Application Discontinuation
- 1999-12-20 AU AU19408/00A patent/AU1940800A/en not_active Abandoned
- 1999-12-20 EP EP99963109A patent/EP1214041A2/en not_active Withdrawn
- 1999-12-20 JP JP2000589136A patent/JP2002542148A/en not_active Withdrawn
Also Published As
Publication number | Publication date |
---|---|
EP1214041A2 (en) | 2002-06-19 |
CA2358492A1 (en) | 2000-06-29 |
WO2000037022A2 (en) | 2000-06-29 |
WO2000037022A3 (en) | 2002-06-13 |
JP2002542148A (en) | 2002-12-10 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
AU2301699A (en) | System for the treatment of wafers | |
HUP0100765A3 (en) | Composition for the treatment of halitosis | |
AU1958897A (en) | Egf-genistein conjugates for the treatment of cancer | |
AU2935200A (en) | Compounds for the treatment of obesity | |
AU2212299A (en) | Compositions and methods for the treatment of tumor | |
AU3891299A (en) | Combination therapy for treatment of depression | |
AU2882299A (en) | Anti-asthma therapy | |
IL142588A0 (en) | Therapy for improving cognition | |
AU2508597A (en) | Drug for the treatment of tumours | |
AU1772399A (en) | Well treatment | |
AU2424895A (en) | Substituted spirodienes for the treatment of inflammation | |
AU5038299A (en) | Process for the biocidal treatment of surfaces | |
AU2740899A (en) | Treatment of liquids | |
AU5056099A (en) | Compounds for use in the treatment of inflammation | |
AU3187595A (en) | Compounds for the treatment of restenosis | |
HUP0101947A3 (en) | Combination for the treatment of tumors | |
AU2021601A (en) | Composition for the treatment of dandruff | |
AU3814599A (en) | Use of erythropoietin for the treatment of haemochromatoses | |
AU1940800A (en) | Combination therapy for the treatment of sepsis | |
IL135994A0 (en) | Combination therapy for the treatment of aids | |
AU4032799A (en) | Device for the treatment of bottles | |
AU2566201A (en) | Compounds and methods for the treatment of pain | |
AUPP375198A0 (en) | An anticorrosion treatment | |
AU1594397A (en) | Use of colostrum for the treatment of constipation | |
AUPP229598A0 (en) | Treatment of sunburn |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
MK6 | Application lapsed section 142(2)(f)/reg. 8.3(3) - pct applic. not entering national phase |